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Virus Classification:
• Discovery: Uganda, 1937               
Detected in U.S. 1999
• Family: Flaviviridae
Other members: Dengue Fever, Tick 
Borne Encephalitis, Yellow Fever, and Zika 
Virus











• Ig’s produced by B-cells
(after infection)






Title and Content Layout with Chart
Researcher: IgM Persistance: RT-PCR: Patients:
• A Papa, 2015 3 years post No 10 of 26
• K Murray, 2013 1,6, 8 years post No 42, 34, 23%
• K Murray, 2010 Yes, 6.7 years Yes, + 5 of 25
• K Gibney, Baty 2010 Yes, 6 years Yes, - 40
Serosurvey Conducted with IgM and IgG Titers
Urine Collection Assessing Viral Presence
Researcher: IgM/IgG Positive: RT-PCR:
K murray, 2013, Percentages of participants (N = 163) with detectable 






Primers for Protein Genes:
• prM, and M: pre-membrane and 
membrane proteins
• E: envelope protein
• C: capsid protein
RT-PCR in combination with ELISA 
• Identify and track subjects infected or previously infected with WNV
• Assess additional subjects expressing high titration of IgM long after exposure
• Increase sample population and testing time frame
• Test individuals for cryptic infection through reverse transcriptase PCR
• Investigate if IgM and IgG are elevated in tandem with virus replication
CWC Longitudinal Study
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